A startup designing and licensing inhaler technology has announced Quattrii – the first ever dry powder inhaler (DPI) engine capable of delivering large volumes of biologic and mRNA molecules in a single inhalation.  Cambridge Healthcare Innovations (CHI) has designed Quattrii in an attempt to transform the delivery of drugs for conditions that affect the lungs … Continue reading Cambridge startup’s inhaler tech can tackle lung problems